SCHEMBL4490476

SCHEMBL4490476

Cc1[nH]c(C)c(-c2c[nH]c(-c3ccccc3)cc2=O)c(=O)c1Br

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 1/20 0.38
HPGD P15428 3/20 0.37
LMNA P02545 3/20 0.37
HSD17B10 Q99714 3/20 0.37
KDM4E B2RXH2 2/20 0.37
TP53 P04637 2/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
NPC1 O15118 1/20 0.37
MAPT P10636 1/20 0.37
ADORA2A P29274 3/20 0.36
ADORA1 P30542 3/20 0.36
BRD4 O60885 2/20 0.36
CTSV O60911 3/20 0.35
CTSL P07711 3/20 0.35
NPSR1 Q6W5P4 2/20 0.35
TUBB4A P04350 2/20 0.35
TUBB P07437 2/20 0.35
TUBA3C P0DPH7 2/20 0.35
TUBA1B P68363 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4487870 0.89 SLC2A1 (0.40) SLC2A1HPGDLMNAHSD17B10KDM4E
SCHEMBL4464654 0.89 ADORA2A (0.39) SLC2A1HPGDHSD17B10KDM4ERAB9A
SCHEMBL4484311 0.87 BRD4 (0.38) SLC2A1MAPTBRD4GAAKMT2A
SCHEMBL4487288 0.86 PTGS2 (0.39) SLC2A1BRD4
SCHEMBL4479166 0.85 TYMP (0.34) SLC2A1ALDH1A1CDK5GSK3B
SCHEMBL4472791 0.85 SLC2A1 (0.46) SLC2A1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL4475104 0.85 SLC2A1 (0.40) SLC2A1
SCHEMBL4493394 0.84 SLC2A1 (0.52) SLC2A1KDM4ESMN1; SMN2MAPTBRD4
SCHEMBL4486516 0.84 ADORA2A (0.41) SLC2A1NPC1ADORA2AADORA1CDC7
SCHEMBL4475903 0.83 CTSV (0.46) SLC2A1MAPTCTSVCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7579353-B2 Pyridinone derivatives against malaria GLAXO GROUP LIMITED (GB) 2009-08-25 US disclosed
US-20080287461-A1 Pyridinone Derivatives Against Malaria GLAXO GROUP LIMITED (GB) 2008-11-20 US disclosed
EP-1858876-A2 PYRIDINONE DERIVATIVES AGAINST MALARIA GLAXO GROUP LIMITED (GB) 2007-11-28 EP disclosed
WO-2006094799-A2 PYRIDINONE DERIVATIVES AGAINST MALARIA GLAXO GROUP LIMITED (GB) 2006-09-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287461-A1 Pyridinone Derivatives Against Malaria G6PD, PNPO, PLPBP SLC2A1 2278/4885HPGD 213/4885LMNA 2161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.